Lawsuits Filed Against BLU, XL and VRM - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / April 19, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
BELLUS Health Inc. (NASDAQ: BLU)
CONTACT JAKUBOWITZ ABOUT BLU:
https://claimyourloss.com/securities/bellus-health-inc-loss-submission-form/?id=14851&from=1
Class Period: September 5, 2019 - July 5, 2020
Lead Plaintiff Deadline: May 17, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: while BLU-5937's "high selectivity" contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company's Phase 2 trial.
XL Fleet Corp. (NYSE: XL)
CONTACT JAKUBOWITZ ABOUT XL:
https://claimyourloss.com/securities/xl-fleet-corp-loss-submission-form/?id=14851&from=1
Class Period: October 2, 2020 - March 2, 2021
Lead Plaintiff Deadline: May 7, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) XL Fleet's salespeople were pressured to inflate their sales pipelines to boost the Company's reported sales and backlog; (2) at least 18 of the 33 customers that XL featured were inactive and had not placed an order since 2019; (3) XL's technology had been materially overstated and offered only 5% to 10% of fleet savings; (4) XL lacks the supply chain and engineers to roll out new products on the announced timelines; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Vroom, Inc. (NASDAQ: VRM)
CONTACT JAKUBOWITZ ABOUT VRM:
https://claimyourloss.com/securities/vroom-inc-loss-submission-form/?id=14851&from=1
Class Period: June 9, 2020 - March 3, 2021
Lead Plaintiff Deadline: May 21, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Vroom had not demonstrated that it was able to control and scale growth in respect to its salesforce to meet the demand for its products; (2) as a result, the Company was forced to discount aged inventory to move through its retail channels or liquidated in its wholesale channels; (3) as a result, the ecommerce gross profit per unit was reasonably likely to decline; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/641159/Lawsuits-Filed-Against-BLU-XL-and-VRM--Jakubowitz-Law-Pursues-Shareholders-Claims
